Neonatal platelets differentiate monocytes to a myeloid-derived suppressor cell phenotype

Preeti Maurya1, Daniel O'Reilly2, Zachary Hilt3

  • 1Aab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY.

Blood
|April 14, 2026
PubMed

Insights

Neonatal platelets, unlike adult platelets, promote monocytes to become myeloid-derived suppressor cells (MDSCs) that limit T-cell activation. This immune-suppressing role of neonatal platelets may explain adverse outcomes from platelet transfusions in newborns.

Area of Science:

  • Immunology
  • Neonatal Medicine
  • Hematology

Background:

  • Adult and neonatal platelets differ in immune molecule expression.
  • Predicting platelet-immune cell interactions in neonates is complex due to varying factors.
  • Previous studies showed adult, but not neonatal, platelet transfusions increased monocyte trafficking in neonatal mice.

Purpose of the Study:

  • To investigate the distinct immune effects of neonatal versus adult platelets on monocytes.
  • To determine the mechanism by which neonatal platelets influence T-cell activation.
  • To explore the implications of these findings for neonatal platelet transfusions.

Main Methods:

  • Incubation of monocytes with neonatal or adult platelets/releasates.
  • Assessment of monocyte phenotype (e.g., PD-L1 expression) and T-cell activation in vitro.
  • In vivo studies using a neonatal mouse model and an asthma-like model.
  • Analysis of prostaglandin E2 (PGE2) and EP4 signaling pathways.

Main Results:

  • Neonatal platelets, but not adult platelets, induced a myeloid-derived suppressor cell (MDSC) phenotype in monocytes.
  • MDSCs generated by neonatal platelets exhibited increased PD-L1 expression.
  • Monocytes pre-incubated with neonatal platelets or releasates suppressed T-cell activation both in vitro and in vivo.
  • Neonatal platelet-induced immune suppression was mediated by increased PGE2 production signaling through monocyte EP4 receptors.

Conclusions:

  • Neonatal platelets possess immune-limiting functions in the neonatal period by suppressing T-cell responses indirectly.
  • These findings suggest a mechanism contributing to adverse outcomes observed with neonatal platelet transfusions.
  • Understanding these distinct platelet functions is crucial for optimizing neonatal care.